Tuberculosis Research Today is a free monthly online journal that collates and summarizes the latest research about Tuberculosis, including details on symptoms, causes, treatment, pulmonary, mycobacterium.

Volume 6 (2009), Issue 7 (July)

1. Infectious complications of tumor necrosis factor blockade.
   Curr Opin Infect Dis, 22(4): 403-9. [Abstract] [Full-text]
2. MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis.
   Vaccine, 27(33): 4402-7. [Abstract] [Full-text]
3. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
   Vaccine, 27(33): 4412-23. [Abstract] [Full-text]
4. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay.
   Ophthalmology, 116(7): 1391-6. [Abstract] [Full-text]
5. Diagnostic value of endobronchial ultrasonography for pulmonary tuberculosis.
   J Thorac Cardiovasc Surg, 138(1): 179-84. [Abstract] [Full-text]
6. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis.
   PLoS Pathog, 5(7): e1000500. [Abstract] [Full-text]
7. Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis.
   PLoS Comput Biol, 5(7): e1000423. [Abstract] [Full-text]
8. Co-Infection of cattle with Fasciola hepatica and Mycobacterium bovis- immunological consequences.
   Transbound Emerg Dis, 56(6): 269-74. [Abstract] [Full-text]
9. Review of the diagnosis and study of tuberculosis in non-bovine wildlife species using immunological methods.
   Transbound Emerg Dis, 56(6): 215-27. [Abstract] [Full-text]
10. WC1(+) gammadelta T cells indirectly regulate chemokine production during mycobacterium bovis infection in SCID-bo mice.
    Transbound Emerg Dis, 56(6): 275-84. [Abstract] [Full-text]
11. Gene expression profiling of the host response to Mycobacterium bovis infection in cattle.
    Transbound Emerg Dis, 56(6): 204-14. [Abstract] [Full-text]
12. Antigen mining to define Mycobacterium bovis antigens for the differential diagnosis of vaccinated and infected animals: A VLA perspective.
    Transbound Emerg Dis, 56(6): 240-7. [Abstract] [Full-text]
13. Autophagy and the immune response to TB.
    Transbound Emerg Dis, 56(6): 248-54. [Abstract] [Full-text]
14. Evaluation of granulysin and perforin as candidate biomarkers for protection following vaccination with Mycobacterium bovis BCG or M. bovisDeltaRD1.
    Transbound Emerg Dis, 56(6): 228-39. [Abstract] [Full-text]
15. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity.
    J Immunol, 183(2): 1301-12. [Abstract] [Full-text]
16. Mycobacterium bovis bacillus Calmette-Guérin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis.
    J Immunol, 183(2): 1337-45. [Abstract] [Full-text]
17. Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates.
    Vaccine, 27(34): 4709-17. [Abstract] [Full-text]
18. Engagement of Toll-like receptor 2 on CD4(+) T cells facilitates local immune responses in patients with tuberculous pleurisy.
    J Infect Dis, 200(3): 399-408. [Abstract] [Full-text]
19. A retrospective evaluation of completion rates, total cost, and adverse effects for treatment of latent tuberculosis infection in a public health clinic in central massachusetts.
    Clin Infect Dis, 49(3): 424-7. [Abstract] [Full-text]
20. Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico.
    Am J Public Health, 99(8): 1491-5. [Abstract] [Full-text]
21. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.
    J Antimicrob Chemother, 64(2): 263-6. [Abstract] [Full-text]
22. Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1.
    J Infect Dis, 200(2): 288-98. [Abstract] [Full-text]
23. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    J Antimicrob Chemother, 64(2): 388-91. [Abstract] [Full-text]
24. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa--an upward trend.
    Am J Public Health, 99(8): 1486-90. [Abstract] [Full-text]
25. Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis.
    BMC Infect Dis, 9: 99. [Abstract] [Full-text]
26. CarD is an essential regulator of rRNA transcription required for Mycobacterium tuberculosis persistence.
    Cell, 138(1): 146-59. [Abstract] [Full-text]
27. Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums.
    Proc Biol Sci, 276(1669): 2987-95. [Abstract] [Full-text]
28. Mycobacterial survival strategies in the phagosome: defence against host stresses.
    Cell Microbiol, 11(8): 1170-8. [Abstract] [Full-text]
29. Mycobacterium requires an all-around closely apposing phagosome membrane to maintain the maturation block and this apposition is re-established when it rescues itself from phagolysosomes.
    Cell Microbiol, 11(8): 1190-207. [Abstract] [Full-text]
30. Hypoxia: a window into Mycobacterium tuberculosis latency.
    Cell Microbiol, 11(8): 1151-9. [Abstract] [Full-text]
31. Peptides of a novel Mycobacterium tuberculosis-specific cell wall protein for immunodiagnosis of tuberculosis.
    J Infect Dis, 200(4): 571-81. [Abstract] [Full-text]
32. 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection.
    Immunology, 127(4): 539-48. [Abstract] [Full-text]
33. CTLA4 autoimmunity-associated genotype contributes to severe pulmonary tuberculosis in an African population.
    PLoS One, 4(7): e6307. [Abstract] [Full-text]
34. Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis.
    Clin Chim Acta, 406(1): 98-102. [Abstract] [Full-text]
35. Strong antibody responses to Mycobacterium tuberculosis PE-PGRS62 protein are associated with latent and active tuberculosis.
    Infect Immun, 77(8): 3337-43. [Abstract] [Full-text]
36. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
    Infect Immun, 77(8): 3364-73. [Abstract] [Full-text]
37. CD8 T Cells in old mice contribute to the innate immune response to Mycobacterium tuberculosis via interleukin-12p70-dependent and antigen-independent production of gamma interferon.
    Infect Immun, 77(8): 3355-63. [Abstract] [Full-text]
38. Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.
    Antimicrob Agents Chemother, 53(8): 3353-6. [Abstract] [Full-text]
39. Cervical tuberculosis detection in Papanicolaou-stained smear: case report with review of literature.
    Diagn Cytopathol, 37(8): 592-5. [Abstract] [Full-text]
40. Epithelioid cell cluster in cerebrospinal fluid: an unusual finding in tubercular meningitis.
    Diagn Cytopathol, 37(8): 596-9. [Abstract] [Full-text]
41. Devastating yet treatable complication of tuberculous meningitis: the resistant TB abscess.
    Childs Nerv Syst, 25(9): 1105-6; discussion 1107, 1109-10. [Abstract] [Full-text]
42. Aneurysmal appearance of medium-sized bronchi: a peripheral manifestation of endobronchial tuberculosis.
    AJR Am J Roentgenol, 193(2): W95-9. [Abstract] [Full-text]
43. Serodiagnostic contributions of antibody titers against mycobacterial lipid antigens in Mycobacterium avium complex pulmonary disease.
    Clin Infect Dis, 49(4): 529-35. [Abstract] [Full-text]
44. NKG2D-dependent IL-17 production by human T cells in response to an intracellular pathogen.
    J Immunol, 183(3): 1940-5. [Abstract] [Full-text]
45. Tuberculosis into the 2010s: is the glass half full?
    Clin Infect Dis, 49(4): 574-83. [Abstract] [Full-text]
46. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Bioorg Med Chem, 17(15): 5716-21. [Abstract] [Full-text]
47. Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area.
    BMC Infect Dis, 9: 105. [Abstract] [Full-text]
48. Projection of the number of patients with tuberculosis in the Netherlands in 2030.
    Eur J Public Health, 19(4): 424-7. [Abstract] [Full-text]
49. Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis.
    Am J Respir Cell Mol Biol, 41(2): 136-45. [Abstract] [Full-text]
50. Giant verrucous nodules in a patient with tuberculosis.
    Am J Dermatopathol, 31(6): 591-3. [Abstract] [Full-text]
51. Social stigma and knowledge of tuberculosis and HIV among patients with both diseases in Thailand.
    PLoS One, 4(7): e6360. [Abstract] [Full-text]
52. First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.
    Int J STD AIDS, 20(8): 566-70. [Abstract] [Full-text]
53. Photodynamic therapy as an adjunct to systemic treatment in a case with unilateral presumed vascularized choroidal tuberculous granuloma.
    Int Ophthalmol, 29(4): 293-6. [Abstract] [Full-text]
54. Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods.
    Lancet Infect Dis, 9(8): 505-11. [Abstract] [Full-text]
55. In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv.
    Int J Antimicrob Agents, 34(3): 226-30. [Abstract] [Full-text]
56. Flare-up of genital tuberculosis following endometrial aspiration in a patient of generalized miliary tuberculosis.
    Arch Gynecol Obstet, 280(3): 503-4. [Abstract] [Full-text]
57. Renal and miliary tuberculosis in an internationally adopted infant.
    Pediatr Infect Dis J, 28(8): 751-3. [Abstract] [Full-text]
58. Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
    Pediatr Infect Dis J, 28(8): 748-50. [Abstract] [Full-text]
59. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status.
    Pediatr Infect Dis J, 28(8): 669-73. [Abstract] [Full-text]
60. A surgical case of pyothorax-associated lymphoma of T-cell origin arising from the chest wall in chronic empyema.
    Ann Thorac Surg, 88(2): 642-5. [Abstract] [Full-text]
61. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis.
    Cytokine, 47(2): 132-6. [Abstract] [Full-text]
62. Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis.
    Vaccine, 27(37): 5152-60. [Abstract] [Full-text]
63. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
    Am J Respir Crit Care Med, 180(3): 273-80. [Abstract] [Full-text]
64. Serum prohepcidin in pulmonary tuberculosis.
    Hematology, 14(4): 245-8. [Abstract] [Full-text]
65. The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa.
    BMC Public Health, 9: 243. [Abstract] [Full-text]
66. Delay in the diagnosis of tuberculosis in Nepal.
    BMC Public Health, 9: 236. [Abstract] [Full-text]
67. Malignant solid tumour, HIV infection and tuberculosis in children: an unholy triad.
    Pediatr Surg Int, 25(8): 697-701. [Abstract] [Full-text]
68. ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria.
    Microbiology, 155: 2664-75. [Abstract] [Full-text]
69. Optimization of a whole-blood gamma interferon assay for detection of Mycobacterium bovis-infected cattle.
    Clin Vaccine Immunol, 16(8): 1196-202. [Abstract] [Full-text]
70. Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.
    Clin Vaccine Immunol, 16(8): 1203-12. [Abstract] [Full-text]
71. Short-term reproducibility of a commercial interferon gamma release assay.
    Clin Vaccine Immunol, 16(8): 1170-5. [Abstract] [Full-text]
72. Public-private partnership tackles TB challenges in parallel.
    Nat Rev Drug Discov, 8(8): 599-600. [Abstract] [Full-text]
73. Evaluation of GenoType mycobacteria direct assay in comparison with Gen-Probe Mycobacterium tuberculosis amplified direct test and GenoType MTBDRplus for direct detection of Mycobacterium tuberculosis complex in clinical samples.
    J Clin Microbiol, 47(8): 2601-3. [Abstract] [Full-text]
74. Mycobacterium tuberculosis in Ontario, Canada: Insights from IS6110 restriction fragment length polymorphism and mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping.
    J Clin Microbiol, 47(8): 2651-4. [Abstract] [Full-text]
75. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis.
    J Clin Microbiol, 47(8): 2520-4. [Abstract] [Full-text]
76. Implementation of the thin layer agar method for diagnosis of smear-negative pulmonary tuberculosis in a setting with a high prevalence of human immunodeficiency virus infection in Homa Bay, Kenya.
    J Clin Microbiol, 47(8): 2632-4. [Abstract] [Full-text]
77. MR imaging of the posterior hypophysis in children with tuberculous meningitis.
    Eur Radiol, 19(9): 2249-54. [Abstract] [Full-text]

© 2004-2012 Tuberculosis Research Today. All Rights Reserved.